Latest / Decera Clinical Education Oncology Podcast
Role of the Multidisciplinary Team in Achieving Comprehensive and Individualized Care of Patients with HR-positive/HER2-negative Metastatic Breast Cancer and Preexisting Comorbidities
In this podcast episode, Sara A. Hurvitz, MD, FACP, La-Urshalar B. Brock, FNP-BC, CNM, and Jordan Hill, PharmD, BCOP, discuss the important role of the multidisciplinary team in achieving comprehensive and individualized care of patients with HR-positive/HER2-negative metastatic breast cancer and preexisting comorbidities, including:
Key Comorbidities in Patients with HR+/HER2- MBC
Impact of Polypharmacy
Role of APPs in Comprehensive Care
Role of CDK4/6 Inhibitors and Other Treatments for HR+/HER2- MBC
Utility of RWE data
Communicating Treatment Options With Patients and Caregivers…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.